These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7964514)

  • 1. Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.
    de Hon FD; Ehlers M; Rose-John S; Ebeling SB; Bos HK; Aarden LA; Brakenhoff JP
    J Exp Med; 1994 Dec; 180(6):2395-400. PubMed ID: 7964514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130.
    de Hon FD; ten Boekel E; Herrman J; Clement C; Ehlers M; Taga T; Yasukawa K; Ohsugi Y; Kishimoto T; Rose-John S
    Cytokine; 1995 Jul; 7(5):398-407. PubMed ID: 7578977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
    Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G
    Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.
    Sporeno E; Savino R; Ciapponi L; Paonessa G; Cabibbo A; Lahm A; Pulkki K; Sun RX; Toniatti C; Klein B; Ciliberto G
    Blood; 1996 Jun; 87(11):4510-9. PubMed ID: 8639818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells.
    Ehlers M; de Hon FD; Bos HK; Horsten U; Kurapkat G; van De Leur HS; Grötzinger J; Wollmer A; Brakenhoff JP; Rose-John S
    J Biol Chem; 1995 Apr; 270(14):8158-63. PubMed ID: 7713920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of a receptor super-antagonist of human interleukin-6.
    Savino R; Ciapponi L; Lahm A; Demartis A; Cabibbo A; Toniatti C; Delmastro P; Altamura S; Ciliberto G
    EMBO J; 1994 Dec; 13(24):5863-70. PubMed ID: 7813426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface.
    Salvati AL; Lahm A; Paonessa G; Ciliberto G; Toniatti C
    J Biol Chem; 1995 May; 270(20):12242-9. PubMed ID: 7744875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism.
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Fujita N; Tsuchiya M; Koishihara Y; Ohsugi Y; Nakagawa M
    Leukemia; 1995 Apr; 9(4):711-8. PubMed ID: 7723407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
    Lasfar A; Wietzerbin J; Billard C
    Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
    Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
    Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
    Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
    Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
    Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
    Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a human interleukin-6 receptor antagonist.
    Brakenhoff JP; de Hon FD; Fontaine V; ten Boekel E; Schooltink H; Rose-John S; Heinrich PC; Content J; Aarden LA
    J Biol Chem; 1994 Jan; 269(1):86-93. PubMed ID: 8276883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an interleukin 6 cytokine family antagonist protein from a marine sponge, Callyspongia sp.
    Peppard JV; Loo P; Sills MA; Munster D; Pomponi SA; Wright AE
    J Biol Chem; 1996 Mar; 271(13):7281-4. PubMed ID: 8631742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).
    Van Riet I; De Greef C; Aharchi F; Woischwill C; De Waele M; Bakkus M; Lacor P; Schots R; Van Camp B
    Leukemia; 1997 Feb; 11(2):284-93. PubMed ID: 9009094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells.
    Burger R; Neipel F; Fleckenstein B; Savino R; Ciliberto G; Kalden JR; Gramatzki M
    Blood; 1998 Mar; 91(6):1858-63. PubMed ID: 9490667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a soluble IL-6 receptor alpha mutant C277D/H280I expressed in E.coli.
    Duan J; Wang J; Cai X; Wang L; Liu H; Zou M
    Biochem Mol Biol Int; 1997 May; 41(6):1101-8. PubMed ID: 9161704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
    Tamura T; Udagawa N; Takahashi N; Miyaura C; Tanaka S; Yamada Y; Koishihara Y; Ohsugi Y; Kumaki K; Taga T
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11924-8. PubMed ID: 8265649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.